Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Branch

Showing results (11-20 of 251) with videos related to

Pageof 26
Sort By:
Clinical Pharmacology and Therapeutics|March 1, 1988
Therapeutic advisory program: an opportunity for clinical pharmacologyR A Branch, P Johnston
Drug Safety|March 1, 1990
Amphotericin B nephrotoxicityR Sabra, R A Branch
Antimicrobial Agents and Chemotherapy|December 1, 1991
Mechanisms of amphotericin B-induced decrease in glomerular filtration rate in ratsR Sabra, R A Branch
European Journal of Pharmacology|May 12, 1992
Effect of amphotericin B on intracellular calcium levels in cultured glomerular mesangial cellsR Sabra, R A Branch
Seminars in Liver Disease|November 1, 1983
Clearance by the liver: current concepts in understanding the hepatic disposition of drugsD Larrey, R A Branch
Clinical Pharmacology and Therapeutics|October 1, 1985
Stereoselective mephobarbital hydroxylation cosegregates with mephenytoin hydroxylationA Küpfer, R A Branch
The American Journal of Medicine|April 1, 1986
Is carbaryl as safe as its reputation? Does it have a potential for causing chronic neurotoxicity in humans?R A Branch, E Jacqz
Clinical Pharmacology and Therapeutics|August 1, 1977
Pharmacokinetics and pharmacodynamics of ethanol, whiskey, and ethanol with n-propyl, n-butyl, and iso-amyl alcoholsR M Auty, R A Branch
Clinical Pharmacokinetics|January 1, 1976
Propranolol disposition in chronic liver disease: a physiological approachR A Branch, D G Shand
British Journal of Clinical Pharmacology|January 1, 1984
Enzyme induction and beta-adrenergic receptor blocking drugsR A Branch, R J Herman
Pageof 26

Showing results (11-20 of 251) with videos related to

Sort By:
Pageof 26
Clinical Pharmacology and Therapeutics|March 1, 1988
Therapeutic advisory program: an opportunity for clinical pharmacologyR A Branch, P Johnston
Drug Safety|March 1, 1990
Amphotericin B nephrotoxicityR Sabra, R A Branch
Antimicrobial Agents and Chemotherapy|December 1, 1991
Mechanisms of amphotericin B-induced decrease in glomerular filtration rate in ratsR Sabra, R A Branch
European Journal of Pharmacology|May 12, 1992
Effect of amphotericin B on intracellular calcium levels in cultured glomerular mesangial cellsR Sabra, R A Branch
Seminars in Liver Disease|November 1, 1983
Clearance by the liver: current concepts in understanding the hepatic disposition of drugsD Larrey, R A Branch
Clinical Pharmacology and Therapeutics|October 1, 1985
Stereoselective mephobarbital hydroxylation cosegregates with mephenytoin hydroxylationA Küpfer, R A Branch
The American Journal of Medicine|April 1, 1986
Is carbaryl as safe as its reputation? Does it have a potential for causing chronic neurotoxicity in humans?R A Branch, E Jacqz
Clinical Pharmacology and Therapeutics|August 1, 1977
Pharmacokinetics and pharmacodynamics of ethanol, whiskey, and ethanol with n-propyl, n-butyl, and iso-amyl alcoholsR M Auty, R A Branch
Clinical Pharmacokinetics|January 1, 1976
Propranolol disposition in chronic liver disease: a physiological approachR A Branch, D G Shand
British Journal of Clinical Pharmacology|January 1, 1984
Enzyme induction and beta-adrenergic receptor blocking drugsR A Branch, R J Herman
Pageof 26